Global Monocyte Activation Tests Market by Product (Monocyte Activation Test Kits, Reagents), Source (Cell Line-based, PBMC-based), Application, End-user - Forecast 2024-2030- Product Image

Sale

Global Monocyte Activation Tests Market by Product (Monocyte Activation Test Kits, Reagents), Source (Cell Line-based, PBMC-based), Application, End-user - Forecast 2024-2030

Report
194 Pages
March 2024
Region: Global
360iResearch™
ID: 5889470

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Monocyte Activation Tests Market size was estimated at USD 588.82 million in 2023, USD 633.30 million in 2024, and is expected to grow at a CAGR of 5.23% to reach USD 841.46 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Monocyte Activation Tests Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Monocyte Activation Tests Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Monocyte Activation Tests Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, CellMade Laboratories, Charles River Laboratories International, Inc, Eurofins Scientific SE, GenScript Biotech Corporation, Lonza Group Ltd., Lps-Biosciences, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories, LLC by Sotera Health Company, SOLVIAS AG, Thermo Fisher Scientific Inc., and Wickham Micro Limited.

Market Segmentation & Coverage

This research report categorizes the Monocyte Activation Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Monocyte Activation Test Kits
- Reagents
Source
- Cell Line-based
- PBMC-based
Application
- Drug Development
- Medical devices Testing
- Vaccine Development
End-user
- Biotechnology Companies
- Medical Device Manufacturers
- Pharmaceutical Manufacturers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Monocyte Activation Tests Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Monocyte Activation Tests Market?
What are the technology trends and regulatory frameworks in the Monocyte Activation Tests Market?
What is the market share of the leading vendors in the Monocyte Activation Tests Market?
Which modes and strategic moves are suitable for entering the Monocyte Activation Tests Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Monocyte Activation Tests Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising emphasis on patient safety and demand for safe and more reliable pyrogen testing
5.1.1.2. Growing initiatives for animal-based in-vitro alternatives
5.1.1.3. Increasing investments in the pharmaceutical sector by private and public sectors
5.1.2. Restraints
5.1.2.1. Capital intensive development process of MAT kits and reagents
5.1.3. Opportunities
5.1.3.1. Launch of newly developed monocyte activation test kits
5.1.3.2. Rising healthcare infrastructure and spending across economies
5.1.4. Challenges
5.1.4.1. Stringent regulatory hurdles associated with approval of MAT kits and reagents
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Monocyte Activation Tests Market, by Product

6.1. Introduction
6.2. Monocyte Activation Test Kits
6.3. Reagents

7. Monocyte Activation Tests Market, by Source

7.1. Introduction
7.2. Cell Line-based
7.3. PBMC-based

8. Monocyte Activation Tests Market, by Application

8.1. Introduction
8.2. Drug Development
8.3. Medical devices Testing
8.4. Vaccine Development

9. Monocyte Activation Tests Market, by End-user

9.1. Introduction
9.2. Biotechnology Companies
9.3. Medical Device Manufacturers
9.4. Pharmaceutical Manufacturers

10. Americas Monocyte Activation Tests Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Monocyte Activation Tests Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Monocyte Activation Tests Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Becton, Dickinson and Company
14.1.2. CellMade Laboratories
14.1.3. Charles River Laboratories International, Inc
14.1.4. Eurofins Scientific SE
14.1.5. GenScript Biotech Corporation
14.1.6. Lonza Group Ltd.
14.1.7. Lps-Biosciences
14.1.8. MAT BioTech BV
14.1.9. Merck KGaA
14.1.10. Microcoat Biotechnologie GmbH
14.1.11. Nelson Laboratories, LLC by Sotera Health Company
14.1.12. SOLVIAS AG
14.1.13. Thermo Fisher Scientific Inc.
14.1.14. Wickham Micro Limited
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. MONOCYTE ACTIVATION TESTS MARKET RESEARCH PROCESS
FIGURE 2. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2023 VS 2030
FIGURE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MONOCYTE ACTIVATION TESTS MARKET DYNAMICS
FIGURE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. MONOCYTE ACTIVATION TESTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MONOCYTE ACTIVATION TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY CELL LINE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PBMC-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICES TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 60. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 149. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 188. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 189. MONOCYTE ACTIVATION TESTS MARKET LICENSE & PRICING

Companies Mentioned

Becton, Dickinson and Company
CellMade Laboratories
Charles River Laboratories International, Inc
Eurofins Scientific SE
GenScript Biotech Corporation
Lonza Group Ltd.
Lps-Biosciences
MAT BioTech BV
Merck KGaA
Microcoat Biotechnologie GmbH
Nelson Laboratories, LLC by Sotera Health Company
SOLVIAS AG
Thermo Fisher Scientific Inc.
Wickham Micro Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	194
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 633.3 Million
Forecasted Market Value ( USD ) by 2030	$ 841.46 Million
Compound Annual Growth Rate	5.2%
Regions Covered	Global
No. of Companies Mentioned	14

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,789GBP €3621EUR$3,749USD£3,099GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4128EUR$4,274USD£3,533GBP €4587EUR$4,749USD£3,925GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4997EUR$5,174USD£4,276GBP €5552EUR$5,749USD£4,752GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5866EUR$6,074USD£5,020GBP €6518EUR$6,749USD£5,578GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7605EUR$7,874USD£6,508GBP €8450EUR$8,749USD£7,231GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Monocyte Activation Tests: Global Strategic Business Report

Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Global Pyrogen Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Global Pyrogen Testing Market by Component (Instruments, Kits, Reagents), Test Type (Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Pyrogen Test), End-User - Forecast 2024-2030

Pyrogen Testing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030